Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer have?
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer has 26 citations in the OpenAlex counts ScholarIQ stores.
When was Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer published?
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer has 2020 year in the ScholarIQ index.
What is the open-access status of Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer?
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer?
The DOI for Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer is on the source record.
What is the PMID of Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer?
The PMID for Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer is on the source record.
What is the OpenAlex record for Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer?
The OpenAlex for Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer is on the source record.